Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis
Phase 2
Recruiting
- Conditions
- Onychomycosis
- Interventions
- Drug: ATB1651-102- Cohort 1Drug: ATB1651-102- Cohort 2Drug: ATB1651-102- Cohort 3Drug: ATB1651-102- Cohort 4Drug: Placebo
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- AmtixBio Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT06327295
- Locations
- 🇳🇿
New Zealand Clinical Research Christchurch, Christchurch, New Zealand
A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis
Phase 1
Completed
- Conditions
- Onychomycosis
- Interventions
- Drug: ATB1651, 2 mg/mLDrug: ATB1651, 5 mg/mLDrug: ATB1651, 10 mg/mLDrug: ATB1651, 20 mg/mLDrug: ATB1651, 30 mg/mLOther: Placebo
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- AmtixBio Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT05089409
- Locations
- 🇳🇿
New Zealand Clinical Research Christchurch, Christchurch, New Zealand
News
No news found